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ABSTRACT
Nucleotide excision repair (NER) is an essential path-
way to remove bulky lesions affecting one strand
of DNA. Defects in components of this repair sys-
tem are at the ground of genetic diseases such as
xeroderma pigmentosum (XP) and Cockayne syn-
drome (CS). The XP complementation group G (XPG)
endonuclease cleaves the damaged DNA strand on
the 3′ side of the lesion coordinated with DNA re-
synthesis. Here, we determined crystal structures of
the XPG nuclease domain in the absence and pres-
ence of DNA. The overall fold exhibits similarities
to other flap endonucleases but XPG harbors a dy-
namic helical arch that is uniquely oriented and de-
fines a gateway. DNA binding through a helix-2-turn-
helix motif, assisted by one flanking -helix on each
side, shows high plasticity, which is likely relevant for
DNA scanning. A positively-charged canyon defined
by the hydrophobic wedge and -pin motifs provides
an additional DNA-binding surface. Mutational anal-
ysis identifies helical arch residues that play critical
roles in XPG function. A model for XPG participation
in NER is proposed. Our structures and biochemi-
cal data represent a valuable tool to understand the
atomic ground of XP and CS, and constitute a start-
ing point for potential therapeutic applications.
INTRODUCTION
The maintenance of genomic integrity is essential for cell
function. Numerous agents including chemicals and radi-
ation may cause DNA damage that, if unrepaired or re-
paired wrongly, generates mutations that can lead to dis-
ease. In order to avoid the formation of irreversible mu-
tations, cells have developed various mechanisms that deal
with the different types of DNA damage (1). The nucleotide
excision repair (NER) system detects and removes DNA
helix-distorting lesions produced by chemical or physical
agents including UV-irradiation. When NER is defective,
humans develop rare autosomal diseases such as xeroderma
pigmentosum (XP), Cockayne syndrome (CS) and trichoth-
iodystrophy, with symptoms ranging from high sun sensitiv-
ity and skin cancer risk to premature aging and neurological
disorders (2,3). Depending on their role in XP disease, eight
complementation groups (XPA-XPG and XPV) have been
described, seven of which relate to proteins participating in
NER (3).
Two NER sub-pathways have been defined, depending
on initial recognition of the lesion (4,5). While in global-
genome NER the XPC-RAD23 heterodimer identifies the
lesion, transcribing RNA polymerases actively detect DNA
damage in the so-called transcription-coupled NER. Both
sub-pathways converge at the subsequent step, where the
ten-subunit complex TFIIH is recruited to open and sta-
bilize a repair bubble of about 24–32 nucleotides (6,7).
TFIIH-mediated bubble opening is stimulated by both XPA
and XPG, with the former binding to the junction between
single and double-stranded DNA (ss/dsDNA junction) on
the 5′side of the lesion (8,9). The undamaged strand is
protected by the replication protein A (RPA) heterotrimer,
while conformational changes reposition XPG and allow
recruitment of the heterodimer formed by XPF and exci-
sion repair cross-complementing 1 (ERCC1), resulting in
the formation of a pre-incision complex (10). The XPF nu-
clease cuts first on the 5′ side of the lesion, followed by 3′
cleavage by XPG (11). Coordinated with removal of the
damaged fragment, the proliferating cell nuclear antigen
(PCNA) fetches DNA polymerases to refill the gap (12).
XPG belongs to the family of flap endonucleases (FEN),
which in mammals encompasses three additional members
(13). FEN1 is involved in DNA replication, EXO1 partic-
ipates in mismatch repair and double-strand break repair,
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while GEN1 resolves Holliday junctions. These enzymes
comprise a catalytic domain that is compact in all cases
except for XPG, which includes a ∼600-residue insertion
at the so-called helical arch. This poorly-conserved inser-
tion presents low complexity and has been shown to me-
diate contacts with TFIIH and RPA (14). The XPG nu-
clease domain is, thus, formed by the association of two
subdomains that are distant in the amino acid sequence.
The N-subdomain comprises residues 1–100 while the I-
subdomain includes residues 760–990, approximately. In
addition, flap endonucleases display C-terminal extensions
of different lengths that mediate interactions with other pro-
teins such as PCNA in the case of FEN1 and XPG (15).
Flap endonucleases recognize ss/dsDNA junctions
formed at different stages of DNA processing (16). GEN1
recognizes and cleaves Holliday junctions, while the pre-
ferred FEN1 substrate is a nicked duplex with both 5′ and
3′ single-stranded flaps and the endonucleolytic substrate
of EXO1 presents a short 5′ flap. The XPG substrate in
NER is a DNA bubble with a 5′ overhang of about 25
nucleotides (17,18), derived from XPF-ERCC1 cleavage
(11). Both artificial DNA bubbles lacking the 5′ overhang
and splayed-arm DNAs mimicking half bubbles can be
cleaved by XPG in vitro (19,20). Flap nucleases cut the
strand with the 5′ overhang at the phosphodiester bond
that links nucleotides +1 and +2 into dsDNA, which is
known as the scissile bond (13).
While the crystal structure of human XPG is currently
unknown, those of human FEN1, EXO1 and GEN1 in
complex with different DNA substrates revealed how these
enzymes recognize and cleave their specific DNA substrates
(21–23). The three enzymes use a helix-2turn-helix (H2TH)
motif (Pfam entry PF06831) to bind the non-cleaved strand
around 6–8 nucleotides into the dsDNA region. This inter-
action, which is mediated by a K+ or Na+ ion, helps position
the scissile bond into the active site, formed by seven con-
served carboxylates. The first exposed base pair of dsDNA
is bound by a hydrophobic wedge, located in the loop be-
tween two -helices. Beyond the active site, the protruding
single-stranded DNA (ssDNA) 5′ flap is clamped by two ad-
ditional -helices forming a helical arch. Functional studies
have shown that in FEN1 the helical arch unfolds to thread
the 5′ flap and then becomes fully ordered to clamp DNA
and allow hydrolysis (24). In addition, FEN1 embraces the
dsDNA beyond the 3′ flap using the hydrophobic wedge -
helices on one face of the DNA double helix, and a -pin
on the opposite face. Next to the hydrophobic wedge, an
acid block that is unique in FEN1 binds the 3′ flap. The
crystal structure of Rad2, the yeast homolog of XPG, in
complex with DNA has been determined (25). While it ex-
hibits a similar binding mode for dsDNA at the H2TH mo-
tif and around the active site, the role of other relevant struc-
tural domains remains undetermined. Moreover, the lack of
structural information for human XPG obscures the molec-
ular basis of essential genetic diseases such as XP and CS.
Here, we report four crystal structures of the human XPG
nuclease domain (XPGn) in the absence and presence of
DNA. The structures unveil the conformation of critical
structural motifs and suggest how the enzyme may rec-
ognize DNA prior to nuclease cleavage. The helical arch
adopts a different orientation as compared to other human
flap nucleases, which is likely relevant for TFIIH interaction
and DNA positioning before incision. We use mutational
analysis to identify positively-charged residues in the heli-
cal arch that play a role in DNA binding and cleavage. Our
results rationalize existing biochemical data and provide an
atomic frame to understand the molecular basis of genetic
diseases associated with NER.
MATERIALS AND METHODS
Protein expression
The cDNA of human XPG (UniProt entry P28715) was
used to generate chimeric gene for XPGn, encoding for
residues 1–112 fused to residues 750–990 through the Gly-
Thr dipeptide. This chimeric gene was cloned into plas-
mids pET28 (Novagen), pET29 (Novagen) and pETM11
(EMBL) to produce three protein variants differing in the
position and cleavability of the purification tag. In the first
construct, pET28 was modified to substitute the thrombin
cleavage site with the human rhinovirus 3C protease tar-
get sequence and the chimeric gene was cloned between
the NdeI and XhoI sites, thus encoding for XPGn with
a cleavable N-terminal His-tag (His-3C-XPGn) that, after
protease cleavage, includes the Gly-Pro-His tripeptide be-
fore the N-terminal Met in XPGn. In the second construct,
the chimeric gene was cloned between the NdeI and XhoI
sites of pET29, encoding for XPGn with a non-cleavable
C-terminal His-tag (XPGn-His). In the third construct, the
chimeric gene was cloned after the Tobacco Etch Virus
(TEV) protease so that, upon protease cleavage of the N-
terminal His-tag (His-TEV-XPGn), the resulting protein
lacks the N-terminal Met in the sequence of XPGn. Point
and double mutants were prepared using standard method-
ologies.
The three constructs were transformed in Escherichia coli
strain BL21 Star (DE3) pRare and expressed differently.
His-3C-XPGn was expressed at 37◦C in 2× YT medium af-
ter induction with 1 mM IPTG at an optical density of 0.6
at 600 nm and harvested after 6 h. For seleno-methionine
labelling, cells were centrifuged prior to induction, resus-
pended in M9 medium supplemented with vitamin B1 and
an amino acid cocktail as described (26) and, after 15 min,
protein expression was induced with 1 mM IPTG. XPGn-
His cells were grown at 37◦C in autoinducible TB medium at
37◦C until an optical density of 2.0 at 600 nm was reached,
then harvested after 18 h incubation at 22◦C. His-TEV-
XPGn was expressed at 25◦C in LB medium after induction
with 1 mM IPTG at an optical density of 0.6 at 600 nm and
harvested after 18 h.
Protein purification
Harvested cells were resuspended in buffer A (50 mM
Tris pH 7.5, 500 mM KCl, 20 mM imidazole, 2 mM -
mercaptoethanol) supplemented with 0.5% Tween-20 and
EDTA-free protease inhibitors (Roche), and lysed by soni-
cation. The lysate was clarified by centrifugation at 40 000g
and 4◦C for 30 min and the supernatant loaded on a His-
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column was washed with 10 volumes of buffer A and the
protein eluted with buffer B (50 mM Tris pH 7.5, 500 mM
KCl, 500 mM imidazole, 2 mM -mercaptoethanol) us-
ing a gradient over 12 column volumes. Fractions contain-
ing XPGn were pooled and dialyzed against buffer C (50
mM Tris pH 7.5, 50 mM KCl, 2 mM -mercaptoethanol)
overnight. For His-3C-XPGn the 3C protease was added
prior to dialysis in a 1:100 mass ratio, while for His-TEV-
XPGn the TEV protease was added after dialysis in a 1:3
mass ratio and incubated for 16 h. In both cases, the pro-
tease and non-cleaved XPGn were removed using a His-
Trap column, following the described protocol with minor
modifications. Subsequently, for the three fusion proteins,
the sample was concentrated and applied to a Superdex 75
column (GE Healthcare) equilibrated in buffer D (20 mM
Tris pH 7.5, 50 mM KCl, 2 mM DTT). Fractions contain-
ing XPGn were concentrated to about 30 mg/ml and stored
at −80◦C. Purified proteins of the three constructs are here-
after termed XPGn1, XPGn2 and XPGn3. The D812A mu-
tants of XPGn1 and XPGn2 were used for crystallization,
while wild-type and point mutants of XPGn3 were used
for functional tests, as all attempts to crystallize the latter
proved unsuccessful.
Preparation of DNA substrates
Synthetic oligonucleotide (Metabion) sequences are shown
in Supplementary Table S2. For crystallization and elec-
trophoretic mobility shift assays, oligonucleotides were dis-
solved in H2O to a final concentration of 8 mM. Annealed
DNAs were prepared by mixing 1:1 molar ratios of partially
complementary strands in buffer E (20 mM Tris pH 7.5, 100
mM KCl), followed by incubation at 95◦C for 10 min and
slow cooling to 4◦C. For nuclease activity tests, the Cy5-
labeled and non-labeled oligonucleotides, i.e. DNA-Ya and
Yb, were annealed in buffer F (20 mM Tris pH 7.5, 150 mM
KCl) following the same protocol.
Crystallization
Crystals of free XPGn1 were obtained by mixing equal vol-
umes of the protein and reservoir buffer containing 25%
polyethylene glycol (PEG) 3350, 100 mM citric acid pH 3.5
at 22◦C. The crystals were cryoprotected by addition of glyc-
erol to a final concentration of 25% and flash frozen in liq-
uid N2. For the XPG-DNA structures, XPGn1 and DNA-1
were mixed in a 1:1.2 molar ratio at a final protein concen-
tration of 20 mg/ml in buffer E, for 30 min at 22◦C prior
to crystallization. Crystals of this complex belonging to two
different space groups were grown at 22◦C in 5% PEG 3350,
50 mM sodium citrate pH 4.0 and cryoprotected in the same
buffer containing 25% ethylene glycol before plunging into
liquid N2. Crystals of free XPGn2 were obtained from an
equimolar mix of the protein at 10 mg/ml in buffer G (20
mM Tris pH 7.5, 100 mM KCl, 20 mM MgCl2, 1 mM DTT)
with splayed-arm DNA, incubated for 30 min at 22◦C prior
to crystallization in 25% PEG 3350, 100 mM Bis–Tris pH
6.5, 200 mM ammonium sulfate. The crystals, showing no
density for DNA, were cryoprotected in the same buffer
containing 25% ethylene glycol before plunging into liquid
N2.
Data collection and structure determination
Diffraction data were collected at 100K at beamlines
PROXIMA-1, ID29 and XALOC at the SOLEIL, ESRF
and ALBA synchrotrons, respectively. Crystallographic
data were processed using XDS (27). A summary of the data
collection and processing statistics is given in Table 1. The
structure of the free XPGn was determined by SAD phas-
ing using a highly-redundant dataset obtained from merg-
ing two selenomethionine derivative crystals. The resulting
model was employed to solve the structures of native XPGn,
either alone or in complex with DNA, using Phaser (28).
Manual building was carried out in Coot (29) while Phenix
(30) and Refmac (31) were used for refinement, with statis-
tics included in Table 1. Stereochemical validation of the
final model was performed with Molprobity (32) and struc-
ture figures were prepared using Pymol.
Nuclease activity tests
25 nM of Cy5-labelled DNA-Y was incubated with 2.5, 5,
25 and 50 nM wild-type or mutant XPGn in buffer H (25
mM Tris pH 7.5, 30 mM KCl, 2.5 mM -mercaptoethanol)
supplemented with 0.5 mM MnCl2 at 37◦C for 60 min in a
reaction volume of 20 l. The reaction was stopped by ad-
dition of an equal volume of buffer J (90% [v/v] formamide,
50 mM EDTA, 0.1% [w/v] bromophenol blue) and heating
for 10 min at 95◦C. The samples (10 l) were loaded onto
16% denaturing TBE–urea 7 M polyacrylamide gel, run for
1 h at 10 W and scanned with a Typhoon Trio (Amersham
Biosciences). For quantification, gels were analyzed with
the ImageJ-NIH software.
Electrophoretic mobility shift assay
For electrophoretic mobility shift assays (EMSA), 2.5 M
of the DNA-2 substrate was incubated with 1, 2, 4 and 8 M
protein in buffer H supplemented with 15% glycerol at 25◦C
for 30 min in a reaction volume of 20 l. The samples (20 l)
were loaded on a 7% native polyacrylamide gel, run at 100
V for 1 h and visualized with ethidium bromide in a GelDoc
2000 (Bio Rad). For quantification, gels were analyzed with
the ImageJ-NIH software.
Thermal shift assay
The SYPRO Orange dye (Invitrogen) was diluted with pro-
tein buffer D from an original 5000× stock solution. Exper-
iments were performed in a iQ5 (BIO-RAD) real-time PCR,
with a sample volume of 20 l and a final protein concetra-
tion of 0.1 mg/ml. Samples were subjected to a temperature
ramp of 3.0◦C/min, from 20 to 90◦C, and fluorescence was
recorded at 570 nm.
RESULTS
Crystal structures of the XPG nuclease domain in the free
state
To investigate the structure of XPGn, we engineered a con-
struct where the central spacer region (residues 113–749)
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Table 1. Data collection and refinement statistics
Free1 (F1) Free2 (F2) Complex1 (C1) Complex2 (C2)
Wavelength (Å) 0.9786 0.9787 0.9795 0.9795
Resolution (Å) 67.6–2.9 (3.0–2.9) 47.8–2.5 (2.6–2.5) 45.8–3.5 (3.6–3.5) 49.7–3.1 (3.2–3.1)
Space group P212121 P42212 I422 P4212
Unit cell (Å) 78.24, 89.56, 268.95 134.22, 134.22, 110.81 129.51, 129.51, 118.73 127.59, 127.59, 118.96
Total reflections 3 458 740 (349 796) 256 046 (28 832) 105 235 (25 414) 504 482 (91 701)
Unique reflections 42 886 (4403) 35 554 (3887) 6627 (1536) 18 419 (3269)
Multiplicity 80.6 (79.4) 7.2 (7.4) 15.9 (16.5) 27.4 (28.1)
Completeness (%) 100 (100) 99.8 (98.1) 99.8 (99.6) 99.9 (99.9)
Mean I/sigma(I) 13.1 (1.0) 14.4 (1.0) 11.1 (0.9) 11.9 (0.9)
R-pim 0.061 (1.072) 0.034 (0.826) 0.052 (0.933) 0.052 (1.203)
CC1/2 0.998 (0.528) 0.999 (0.439) 0.998 (0.827) 0.998 (0.587)
Wilson B-factor 73.01 69.08 132.70 110.52
Reflections used in
refinement
42814 (4201) 35494 (3431) 6552 (618) 18305 (1749)
Reflections used for
R-free
1071 (105) 888 (86) 331 (32) 551 (50)
R-work 0.239 (0.382) 0.203 (0.303) 0.265 (0.489) 0.247 (0.415)
R-free 0.280 (0.399) 0.237 (0.336) 0.291 (0.555) 0.302 (0.460)
CC(work) 0.928 (0.313) 0.957 (0.707) 0.962 (0.664) 0.956 (0.639)
CC(free) 0.831 (0.161) 0.939 (0.647) 0.922 (0.396) 0.862 (0.302)
Protomers in asymmetric
unit
4 2 1 2
Non-hydrogen atoms 10 271 4823 2914 5860
Protein residues 1267 583 313 645
RMS(bonds) 0.014 0.002 0.004 0.003
RMS(angles) 1.88 0.55 0.70 0.56
Ramachandran favored
(%)
96.19 97.00 97.05 95.88
Ramachandran allowed
(%)
3.72 2.65 2.62 4.12
Ramachandran outliers
(%)
0.08 0.35 0.33 0.00
Rotamer outliers (%) 3.79 1.96 0.00 0.00
Clashscore 9.79 3.57 7.74 4.01
Average B-factor 109.27 82.05 212.30 145.28
PDB code 6TUR 6TUS 6TUW 6TUX
Statistics for the highest-resolution shell are shown in parentheses.
and Supplementary Figure S1). For crystallization, we in-
troduced the D812A mutation to abolish the XPG nucle-
ase activity (33). Two versions of the protein were purified
that differ in the presence or absence of extra residues at the
N-terminus (see Materials and Methods). Both constructs
retain the ability to bind splayed-arm DNA (Supplemen-
tary Figure S2A) and were used to determine two crystal
structures of XPGn in the free state, hereafter F1 and F2,
with four and two molecules in the asymmetric unit, re-
spectively (Table 1). XPGn is formed by a 7-stranded cen-
tral -sheet surrounded by 15 -helices (Figure 1B). The
structure presents an overall bean-like shape, reminiscent of
other enzymes of the human flap endonuclease family (21–
23), where structural elements of the family can be identi-
fied. The active site is located in a groove lying roughly at
the center of the enzyme. The D812A mutation explains the
absence of electron density for divalent cations in the active
site, as this residue is required for metal coordination, to-
gether with six additional conserved carboxylates, i.e. D30,
D77, E789, E791, D810 and D861 (Figure 1B, red). In fur-
ther agreement, E791 in our structure presents an orienta-
tion that is incompatible with metal coordination (Supple-
mentary Figure S3A, B).
Above the active site, a helical arch is formed by two
-helices that we labelled 4 (residues 82–97) and 6
(residues 750–779) in accordance with canonical nomencla-
ture (22,23). In the full-length protein, 4 and 6 connect
the N- and I-subdomains through the spacer region, while
in our constructs they link through XPG residues 98–112
plus 2 extra amino acids derived from cloning, which all
appear disordered (Figure 1A-B). This segment, thus, op-
erates as a flexible linker allowing the helical arch to adopt
its native configuration. Helices 4 and 6 are fully ordered
in two F1 molecules, while the N-terminal half of 6 is dis-
ordered in the other two F1 molecules (Supplementary Fig-
ure S3C). In F2 crsytals, both the N-terminal half of 6 and
the entire 4 are disordered (Supplementary Figure S3D).
Comparison of F1 molecules where the arch is fully or-
dered shows that 6 can adopt two distinct conformations
by pivoting on its C-terminal end (Figure 1B). In the open
state, the 4 and 6 backbones lie ∼14 Å apart and define
a gap of ∼11 Å, while in the closed state 6 approaches 4
by about 3 Å. This enables weak interactions at the outer
rim of the arch, leading to the formation of a pore above
the active site with a diameter of ∼9 Å (Figure 1C). The
inner interface is contributed by basic residues K84, K85,
R91 and R92 on the 4 side, and neutral residues on the
6 side. A similar pore in FEN1 was proposed to act as
a gateway for 5′ flap threading prior to nuclease cleavage






/nar/advance-article/doi/10.1093/nar/gkaa688/5895332 by 81263588 user on 25 August 2020
Nucleic Acids Research, 2020 5
Figure 1. Crystal structure of XPGn in the DNA-free state. (A) Bar diagram of the structural motifs in the XPG nuclease domain. The spacer and the
C-terminal tail, absent in our constructs, have been omitted for simplicity. (B) Crystal structures of F1 with open and closed conformations of the helical
arch. Colors are as in panel A for the closed arch conformation, while the open arch conformation is shown in transparent cream color. (C) Surface charge
representation (right) and close-up view of sidechains around the gateway (left) of F1 in the closed configuration of the helical arch. Residues mutated in this
work are labeled with an asterisk. (D) Comparison of residue W34 position in the open (colors as in panel A) and closed (cream color) arch conformations
of F1 molecules.
striking conformational change in the hydrophobic core of
the protein (Figure 1D). In the open state, residue W34 in
2 sits in a hydrophobic pocket that is sealed by a cation–
 interaction with R61 in 3. In contrast, in the closed
state, W34 flips into a looser hydrophobic environment and
inserts between 3 and 6, which both shift in opposite
directions.
The XPG nuclease domain contains additional structural
motifs that are expected to interact with DNA according to
surface charge distribution (Figure 1B-C). On one side of
the active site, the H2TH motif (residues 848–880), compris-
ing 10, 11 and their connecting loop, is flanked by helices
1 (residues 6–12) and 12b (residues 912–918). The latter
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through a linker that is partly disordered. On the other side
of the active site, the hydrophobic wedge (residues 31–67)
includes helix 2, which adopts different configurations due
to W34 changes (see above), helix 3 and their connecting
loop, which is mostly disordered. Finally, the -pin motif
(residues 820–836) comprises strands 6, 7 and the 6–7
loop, which exhibits diverse conformations in the different
DNA-free structures. The mobility of these structural mo-
tifs is likely to play a role in XPG function.
Crystal structures of the XPG nuclease domain in complex
with DNA
To characterize the interaction between XPG and DNA, we
obtained crystals of XPGn in complex with a short splayed-
arm DNA mimicking the 3′ side of the repair bubble (Figure
2A). Two crystal forms were obtained with similar unit cell
dimensions but different symmetry (Table 1). Crystals of
the I422 space group contain one complex in the asymmet-
ric unit, hereafter C1, while those belonging to space group
P4212 contain two distinct complexes, termed C2a and C2b.
In all cases, the dsDNA region of the substrate exhibits clear
density, while it is weaker or absent around the ss/dsDNA
junction (Supplementary Figure S4). This may be due to the
presence of the N-terminal methionine in the crystallized
protein, which hampers access of the 5′ overhang into the
active site. In agreement, nuclease activity tests show that
this construct is unable to cleave splayed-arm DNA in con-
ditions where XPGn lacking the N-terminal methionine is
active (Supplementary Figure S2B). The protein structures
derived from the three complexes exhibit the largest changes
at the helical arch (Figure 2B). In all cases, the arch helices
are fully ordered and adopt the closed state, though 6 in
C2b is halfway tilted towards the open state. Interestingly,
in the three complexes W34 lies within the hydrophobic
pocket, suggesting that DNA binding is sufficient to close
the helical arch and generate a gateway between 4 and 6
(Figure 2C).
Strikingly, while in the three complexes the DNA sub-
strates contacts XPG around 11, the DNA trajectories sig-
nificantly differ (Figure 2B). In both C1 and C2a, DNA
binds XPG with the minor groove facing 11 and 12b,
while the major groove faces 1. However, the DNA in C2a
is tilted by 7◦ towards 1 and away from 12b, relative to
C1. Furthermore, the DNA in C2b binds XPG in the op-
posite orientation, with the major groove facing 11 and
12b, while the minor groove faces 1. As compared to C1,
its trajectory is tilted by 15◦ toward 12b and away from
1. Modeling of an ideal B-DNA on the experimental sub-
strates shows clashes with the 12–12b loop in the case
of C2b or with the -pin in the case of C2a (Figure 2B).
In contrast, a straight B-DNA can be modeled on the C1
substrate with no clashes. Additionally, this peculiar orien-
tation of the C1 substrate leads to partial DNA ordering in
the vicinity of the active site, which allowed us to identify
the damaged and undamaged DNA strands, as well as the
putative scissile bond (Figure 2A).
As mentioned, the main contact involves the H2TH mo-
tif and the undamaged strand in the dsDNA region of the
splayed-arm substrate (Figure 2D). The phosphate group
located seven nucleotides into dsDNA from the putative
scissile bond forms a hydrogen bond with the sidechain of
T873 in 11. This contact is reinforced by the main chain
of residues G870 and V872 in 11, which lie at hydrogen
bond distance from the DNA backbone. Unexpectedly, the
H2TH interaction is not mediated by a K+ ion in our struc-
tures, in spite of its presence in the crystallization buffer.
Nuclease activity tests in the presence of different ions show
that smaller monovalent ions such as Li+ allow splayed-
arm cleavage in the same extent as K+ does (Supplemen-
tary Figure S2C). Besides, the dsDNA region that is most
distal from the scissile bond contacts 12b, likely through
basic residues K913, K916 and K917, all of which lie close
to DNA. This additional interaction is predicted to con-
fer XPG the possibility to bind longer dsDNA segments,
in agreement with DNA protection experiments (34). More-
over, K8 in 1 lies next to the damaged strand within the ds-
DNA region in the vicinity of the active site, suggesting that
this residue may participate in DNA positioning. Addition-
ally, the damaged strand in C1 locates next to -pin residues
R823 and K830, which likely play a role in the interaction
with the ss/dsDNA junction. The hydrophobic wedge rein-
forces this interaction by approach of residue Q37 in 2.
In the three structures, two adjacent copies of each com-
plex relate by a 2-fold crystallographic axis, so that two pro-
tein molecules sandwich two DNA molecules (Figure 2E).
Interestingly, both the hydrophobic wedge and the -pin in-
teract with the symmetry-related DNA molecule, with each
motif contacting DNA from opposite sides of the double
helix. The main interaction involves residue H60 in 3 and
the DNA region that is most distal from the XPG active site,
a contact that is reinforced by K972 in 15 (residues 970–
984). Moreover, the 2–3 loop, which is only partly or-
dered in one of the six DNA-free molecules, becomes fully
ordered in C2b by inserting into the DNA major groove.
While density for this loop is weak, residues R43 and R45
lie close to the DNA backbone. Finally, residues N827 and
K828 from the 6–7 loop contact the DNA region that
is next to the active site (Figure 2D). As a result, the hy-
drophobic wedge and the -pin form a canyon that is rich in
basic residues and extends up to helix 15, at the outer rim
of the XPG nuclease domain (Figure 2C). In summary, our
XPG-DNA structures identify three major DNA-binding
areas in XPG: (i) the H2TH motif and 12b for dsDNA; (ii)
the active site face of the wedge and the -pin for the junc-
tion; and (iii) the canyon formed by the wedge and -pin,
which could accommodate ssDNA or dsDNA. In addition,
while residues K84, K85, R91 and R92 in 4 do not directly
contact DNA in our structures, their vicinity to the active
site and their location at the inner face of the gateway (Fig-
ures 1C and 2C) suggest that they might contact the ssDNA
damaged strand (see below).
Comparison with endonucleases of the flap family
We compared the structure of XPG with that of other mem-
bers in the human structure-specific nuclease superfamily,
i.e. FEN1, EXO1 and GEN1. Superposition of XPGn with
these proteins showed an overall similarity, while impor-
tant differences can be identified (Figure 3A, B). The he-
lical arch in XPG presents a unique configuration. While
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Figure 2. Crystal structure of XPGn in complex with DNA. (A) Schematic representation of the repair bubble and sequence of the crystallized DNA
substrate. A red arrow indicates the scissile bond. (B) Crystal structures of the XPGn–DNA complexes superposed on the protein with experimental (left)
and modelled (right) DNA. (C) Surface charge representation of C1 showing the main DNA interacting regions. (D) Above, crystal structures of C1 and
C2b with depicted sidechains for residues in the vicinity of DNA. Below, schematic representation of DNA-interacting residues in XPG. Residues mutated
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Figure 3. Structural comparison with flap endonucleases. (A) Superposition of XPG in transparent grey with FEN1 (PDB: 3Q8M), EXO1 (PDB: 3QE9)
and GEN1 (PDB: 5T9J). (B) Reported crystal structures of FEN1 (PDB: 3Q8M), EXO1(PDB: 3QE9) and GEN1 (PDB: 5CO8) in complex with DNA,
compared with the C1 structure reported here. A schematic of the specific substrate for each protein is shown below. (C) Superposition of the XPG-DNA
C1 structure in gray and orange onto EXO1-DNA (PDB: 5UZV) in an early pre-incision state, where the EXO1 structure has been removed and its DNA
is shown in blue.
in XPG, GEN1 6 is shorter and 4 is missing. This leads
to the absence of a gateway in GEN1, which rather exhibits
upper and lower gates for ssDNA binding (21), likely due
to different substrate specificity. Furthermore, when com-
pared with FEN1 and EXO1, the helical arch presents a
markedly different configuration, with a significantly longer
6 in XPG and 4 tilted by about 90◦. Moreover, helix 5 in
FEN1 and EXO1 is replaced by a disordered ∼640-residue
spacer in XPG, which determines the specificity of this pro-
tein for DNA bubbles instead of shorter 5′ flaps (13). Ad-
ditionally, the XPG hydrophobic wedge occupies an inter-
mediate position between those observed in GEN1, where
it lies further from the helical arch, and FEN1 or EXO1,
where it lies closer to the arch. This is likely a consequence
of the unique arch configuration in XPG, which allows 2
in the wedge to significantly approach 6 in the arch, sug-
gesting that a crosstalk may operate between these motifs.
Besides, while the H2TH motif arranges similar to other
human flap endonucleases, the 10–11 loop lies closer to
DNA in XPG, which associates with the absence of a K+ ion
mediating the interaction. Moreover, the DNA molecule in
our C1 structure is tilted by ∼15◦ away from the active site,
as compared to other human flap nucleases. This difference
is less pronounced when compared with the structure of an
early reaction intermediate of EXO1 (35), suggesting that
our structures reflect a stage that precedes DNA cleavage
(Figure 3C).
Finally, two additional regions in the protein present re-
markable differences with other members of the human en-
donuclease family. On one side, XPG presents a unique in-
sertion that includes 12b and the 12–12b loop. While
GEN1 contains an insertion in an equivalent position, both
the helix and the loop are significantly longer as compared
to XPG, and the reported structure lacks DNA in this re-
gion (21). On the opposite side, XPG contains helices 14
and 15 at the end of the nuclease domain. Though absent
in EXO1, these helices in FEN1 and GEN1 are involved in
upstream dsDNA binding. Moreover, GEN1 contains an
extra chromodomain that allows binding of longer DNA
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members of the nuclease family, XPG presents unique struc-
tural features that are probably crucial in determining its
specificity for DNA repair bubbles.
We also compared our structures of XPGn with equiv-
alent structures of its yeast homolog, Rad2. The gateway
defined by the XPG helical arch has not been observed in
Rad2 (25), as the N-terminal half of 6 appears disordered
and tilted away from 4 (Supplementary Figure S5A). This
underscores the arch plasticity, presumably related to its pu-
tative interaction with the damaged strand ssDNA. Addi-
tionally, the wedge helix 2 is tilted away from the active site
in activated Rad2 as compared to XPG, associated with a
shorter 3 helix. While this could arise from different DNA
binding in the compared structures, full ordering of 6 in
XPG may determine the conformation of the neighboring
wedge helices. Besides, the 10-11 loop within the H2TH
motif is shifted away from DNA by ∼2 Å in Rad2, concomi-
tant with tilting of 11 (Supplementary Figure S5B). Both
the loop and 11 establish the main interaction with ds-
DNA, which in activated Rad2 is mediated by a K+ ion that
is absent in our XPG structures (see above). A major differ-
ence arises around helices 12 and 12b, at the outer rim of
the dsDNA-interacting region, which shows poor conserva-
tion among orthologues (Supplementary Figure S5C). The
DNA-binding 12b is shorter in XPG due to a unique inser-
tion in yeast at the N-terminus of this helix, while the oppo-
site applies to the DNA-distant 12. Between these helices,
Rad2 displays an additional helix, 12a, that is absent in
our XPG structures. While the XPG 12–12b loop could
fold into a helix as observed for Rad2 (Supplementary Fig-
ure S5A), sequence conservation rather supports that 12a
is lacking in XPG.
Model of activated XPG
To further infer how XPG may act in the later stages of its
catalytic process, we used available structures of flap nucle-
ases in complex with DNA to build a model of activated
XPG. We first took the DNA in the Rad2–DNA structure
(25) to build a model of XPGn in complex with splayed-
arm DNA (Figure 4A). As expected, the damaged strand
in the model clashes with the XPG N-terminal methionine,
which is absent in the active protein in vivo. The undam-
aged strand exhibits minor clashes with 11 in the H2TH
motif, implying small rearrangements in XPG to accommo-
date DNA before catalysis. Comparison of the model with
the structures reported here suggests that DNA accommo-
dation for cleavage requires reorientation of its trajectory,
using the H2TH contact as pivoting point (Movie 1). In ad-
dition, the model indicates that the unique orientation of
4 in XPG may allow basic residues in this helix, includ-
ing R91, R94 and K95, to contact the undamaged strand
4–5 nucleotides downstream of the scissile bond. Besides,
the model shows that the 5′ flap is positioned exactly at the
entrance of the gateway, with residues K84 and R92 in 4
pointing in the direction of the cleaved DNA strand. Inter-
estingly, mutational analysis in the T5 endonuclease showed
that K83, equivalent to K84 in XPG (see below), is abso-
lutely required for exonuclease activity while it is dispens-
able for endonuclease activity (36).
Figure 4. Model of XPG in the activated state. (A) Model of activated
XPG using the DNA in the Rad2 crystal structure (PDB: 4Q10). (B) Model
of activated XPG using the DNA in the T4 RNase H crystal structure
(PDB 2IHN). (C, D) Close-up views of the gateway and the canyon from
the model shown in panel B. Residues mutated in this work are labeled with
an asterisk.
Our structures suggest that the hydrophobic wedge, the
-pin and 15 may play a role in DNA binding beyond the
ss/dsDNA junction. To build a putative model of XPGn in
complex with the 3′ side of the repair bubble, we used the
structure of the FEN1 homolog T4 RNase H, where the
path of both ssDNA strands beyond the junction was ob-
served (37). Apart from minor clashes with dsDNA as seen
in the Rad2-based model, the ssDNA strands adequately
accommodate onto our XPG structure (Figure 4B). The
damaged ssDNA engages inside the gateway with only mi-
nor clashes with 6, which could be avoided with small re-
arrangements in the ssDNA and/or the helical arch. This
raises the possibility of DNA threading in XPG, as de-
scribed for FEN1 (38). The presence of basic residues K84
and R92 in 4 and hydrophobic residues L39 and F769
in 6 is compatible with binding to the ssDNA backbone
and bases, respectively (Figure 4C). Besides, the undam-
aged ssDNA fits in the canyon formed by the hydrophobic
wedge and the -pin motifs. The canyon is interspersed with
basic residues including H60 and R61 in the wedge helix
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commodate the phosphate backbone (Figure 4D). In addi-
tion, four exposed phenylalanine side chains (F67, F68 and
F978) locate in the vicinity of the undamaged strand in our
model and could stabilize exposed ssDNA bases. In sum-
mary, DNA modelling on our XPGn structures provides
hints into DNA binding and cleavage by XPG.
Structure-based mutational analysis
To identify critical XPG residues for DNA binding and in-
cision, we performed an extensive mutational analysis us-
ing EMSA and nuclease activity tests on splayed-arm sub-
strates (Figure 5 and Supplementary Figure S6). We chose
to mutate residues that, according to our XPG-DNA struc-
tures and model of activated XPG, are likely to play a role in
the interaction and/or cleavage of the repair bubble. Muta-
tion of individual basic residues in arch helix 4, which ac-
cording to our model of activated XPG is expected to inter-
act with the 5′ flap, distinctly affects DNA binding. In par-
ticular, R92A decreases DNA binding by about one third,
while K84A produces a subtle effect and R91A binds DNA
as wild-type XPGn. Nevertheless, mutation of any of these
three residues decreases XPG nuclease activity, with R91A
and R92A reducing cleavage by half and one third, respec-
tively, while a complete loss occurs in the case of K84A
in agreement with mutational analysis of T5 endonuclease
(36). The different location of these residues is coherent with
their distinct role in DNA binding and cleavage. Notably,
K84 lies closest to the active site, while the sidechains of R91
and R92 point towards the entrance and exit of the gateway,
respectively (Figures 1C and 4C). Besides, the double mu-
tant R43A/R45A in the hydrophobic wedge loop reduces
the nuclease activity to about half, while DNA binding is
less affected. The location of this loop between arch helix
6 and the positively-charged canyon is coherent with a role
in ssDNA positioning. A second mutant in the hydropho-
bic wedge, H60A, only exhibits a mild decrease in nuclease
activity and no effect in DNA binding. In contrast, muta-
tion of the equivalent position in Rad2 almost entirely sup-
presses nuclease activity (25), which highlights functional
differences between homologues. Additional mutants near
the canyon exhibit marginal or no effect in splayed-arm
DNA binding or cleavage. R823A in the -pin shows ∼10%
reduction in both assays, while K828E in the -pin and
K972E in helix 15 mildly lower DNA cleavage only (Fig-
ures 2D and 4D). On the opposite side of the enzyme, mu-
tants K913A, K916A or K917E in 12b, which binds ds-
DNA next to the H2TH motif (Figure 2D), also present a
minimal or null effect in DNA binding or cleavage. This sug-
gests that, at least individually, these residues have limited
influence on DNA positioning, in contrast to Rad2 where
the K909A mutant abrogates nuclease activity (25), further
underscoring dissimilarities between homologues. Finally,
as expected, mutant D812A in the active site has no influ-
ence on DNA binding while it completely abolishes nucle-
ase activity. This and other mutants highlight the fact that
DNA binding is not sufficient for nuclease activity and indi-
cate that proper DNA positioning is required for cleavage.
In conclusion, basic residues in the helical arch and the hy-
drophobic wedge play key roles in XPG function, while rele-
vant differences are observed between the yeast and human
homologs.
Structural basis of genetic diseases associated to XPG
The structures of XPGn reported here provide an atomic
framework to rationalize XPG mutations found in XP and
CS patients (summarized in (39)). From the thirteen differ-
ent point mutations identified to date, only I290N lies in the
spacer region, absent in our constructs (Supplementary Ta-
ble S1). The remaining twelve localize within XPGn, which
allowed mapping on the C2b structure (Figure 6). An addi-
tional 44-residue insertion in XPGn leading to disease was
also mapped on our structure. Interestingly, all mutations
distribute along an axis running in the longest dimension
of the protein, suggesting that alterations at peripheral ar-
eas affect its DNA repair functionality mildly.
Three mutations cause severe XP/CS phenotypes with
early onset, associated with mental retardation since child-
hood (40,41). They correlate with non-conservative sub-
stitutions in the hydrophobic core of the enzyme and are,
thus, expected to strongly destabilize the structure, as pre-
dicted by DUET (42). P72H likely interferes with the nu-
clease fold at the base of 3 in the wedge, whereas G805R
and W814S affect the structure around the -pin (Supple-
mentary Figure S7). Interestingly, while G805R likely in-
duces major clashes, W814S is predicted to collapse the hy-
drophobic core by removal of a large hydrophobic residue.
Two other mutations cause severe XP/CS phenotypes with
late onset (43). L858P may lead to increased rigidity or dis-
ruption of secondary structure at 10 in the H2TH motif,
essential for DNA binding and positioning. In contrast, the
44-residue insertion within the unique XPG helix 12b is
expected to interfere with dsDNA interaction beyond the
H2TH motif.
The remaining point mutations lead to milder pheno-
types, with symptoms related to high UV light sensitivity
(39,44–48). The conservative L65P mutation may lead to in-
creased rigidity or disruption of secondary structure at 3 in
the wedge, which may influence the helical arch configura-
tion (Supplementary Figure S7). An equivalent rigidifying
effect at the basis of 6 in the helical arch is expected for
L778P. This mutant reinforces the critical role of 6 confor-
mational changes, which we showed to determine the con-
figuration of the gateway. Both A792V and A795T likely
shift 7, which may alter the structure around the neigh-
boring active site. A thermal shift assay using purified pro-
teins shows that either of these mutants severely reduces the
stability of XPGn by 7 and 6.5◦C, respectively (Figure 6B),
suggesting that their associated XP phenotype is related to
structural instability. While predicted to stabilize the nucle-
ase fold according to DUET, the conservative A818V muta-
tion lies at the basis of the -pin and may influence its orien-
tation. The A874T mutation is expected to alter the orien-
tation of 11 in the H2TH motif, which plays a prominent
role in DNA binding according to the structures reported
here.
Finally, two siblings were reported to exhibit a mild XP
phenotype with a heterozygous genotype leading to mu-
tated XPG at A28D or W968C (48). According to DUET,
both mutations are predicted to destabilize the protein, with
A28D exhibiting a stronger effect (Supplementary Table
S1). In agreement, our structure shows that A28 lies within
the hydrophobic core while W968C locates in the 14-15
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Figure 5. Functional analysis of XPG mutants with splayed-arm DNA. Quantification of DNA-2 (2.5 M) binding (A) and DNA-Y (25 nM) cleavage
(B) at varying protein concentrations of XPG wild-type (black circles) and point or double mutants (white triangles). Representative gels are shown in
Supplementary Figure S6. Graphs represent the quantification of at least three independent experiments, with error bars corresponding to the standard
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Figure 6. Structural basis of xeroderma pigmentosum (XP) and Cockayne syndrome (CS). (A) The location of each mutation is represented as spheres,
colored orange for mild phenotypes (XP) or red for severe phenotypes (XP/CS). (B) Thermal shift assay for wild-type XPGn (green) and mutant proteins
A792V (red open circles), A795T (red closed circles) and W968C (orange), as found in patients. Graphs represent the quantification of three independent
experiments, each including a triplicate of every mutant, with error bars corresponding to the standard deviation of each data point. The resulting Tm
values for wild-type, A792V, A795T and W968C are 50.5±0.3, 43.5±1.0, 44.0±0.5 and 46.5±0.5◦C, respectively.
estingly, the W968 sidechain lies next to DNA and forms
a cation- interaction with K972 (Supplementary Figure
S6A), which also locates next to DNA (Figure 2D). More-
over, F316 in FEN1, equivalent to W968 in XPG, is involved
in the recognition of the 3′ flap (49). While a 3′ flap is ab-
sent in repair bubbles, these observations suggest that the
W968C mutation may interfere with DNA binding. To in-
vestigate the effect of this interesting mutation in XPG, we
expressed and purified the W968C mutant and compared
its biochemical properties with those of the wild-type pro-
tein. Our thermal shift assay showed that introduction of
the W968C mutation leads to a reduction of the melting
temperature by 4◦C (Figure 6B). These results support that
structural instability is at the basis of the XP phenotype due
to the W968C mutation.
DISCUSSION
The helical arch is a dynamic region forming a gateway
In this work, we present crystal structures of the human
XPG nuclease domain, both in the absence and presence of
DNA. The nine different atomic models derived from these
structures provide hints into the enzyme architecture and
dynamism. Several structural elements exhibit flexibility,
which is likely relevant for protein function. Movements in
the -pin loop, 11 and 12b are limited to about 3 Å, while
the hydrophobic wedge and the 12–12b loop are essen-
tially disordered, with the exception of C2b where the wedge
orders upon insertion into the DNA major groove. Be-
sides, the helical arch exhibits remarkable conformational
changes from fully-unfolded 4 and half-unfolded 6 to
both completely folded helices. In particular, 6 constitutes
a long, mobile -helix able to form a pore with the uniquely-
oriented 4 helix. An equivalent pore constitutes a gate-
way for 5′ flap threading in FEN1 and EXO1 (24,35), while
GEN1 lacks a gateway in accordance with the absence of
a 5′ flap in Holliday junctions (21). In the case of XPG,
which only cleaves DNA on the 3′ side of the lesion after a
5′ flap containing the damage has been generated by XPF-
ERCC1 on the opposite side of the repair bubble (11), two
scenarios for damaged ssDNA binding can be envisioned.
In the first, the 5′ flap could be threaded through the heli-
cal arch pore before the damage strand is cleaved. In the
second, the 5′ flap could surround the helical arch, most
likely by passing between arch helix 6 and wedge helix 2.
Our model of XPG with T4-FEN DNA showing that the
5′ flap can be hosted inside the gateway would favor the
first hypothesis (Figure 4C). In this model, both K84 and
R92 in arch helix 4 lie close to the 5′ flap ssDNA. Our
functional analysis confirms that mutation of these residues
lowers binding of splayed-arm DNA to XPG, indicating a
role in 5′ flap positioning prior to nuclease attack. More-
over, mutation of K84, R91 or R92 reduces the catalytic
activity of the enzyme, with complete loss of function in
the case of K84, suggesting that it may play a direct role in
catalysis. Additionally, it was shown that 5′ flap nucleotides
1 to 4 from the ss/dsDNA junction are protected in the
XPG-DNA complex (34), which is more likely in the first
scenario. The high plasticity of the arch helices, connected
through a largely-disordered ∼640-residue spacer, is com-
patible with large conformational changes presumably re-
quired for threading. Nevertheless, in contrast to FEN1,
the 5′ flap in the XPG substrate is 24–29 nucleotides long
(17,18) and threading of this long ssDNA would likely re-
quire a massive rearrangement of the repair complex, possi-
bly including TFIIH, which seems unlikely. Moreover, XPG
can cleave artificial bubbles lacking a 5′ flap (20), showing
that threading is not required for DNA cleavage in vitro.
The H2TH motif allows XPG swiveling on dsDNA
Our crystal structures of XPGn in complex with a short
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DNA. The main anchoring point locates at the N-terminus
of 11 within the H2TH motif, as observed for other mem-
bers of the family. Binding of dsDNA beyond this point is
reinforced by interaction with 1 and 12b, the latter being
unique in XPG and its yeast orthologue, Rad2 (25). Our
structures show two strikingly different modes of interac-
tion with dsDNA in this region. The 11 and 12b helices
can either bind the minor or the major groove of DNA, with
each helix contacting one strand of the groove. The minor
groove binding mode likely represents the canonical interac-
tion, as this has been observed in other members of the fam-
ily (Figure 3). Interestingly, we obtained two different struc-
tures of the minor groove binding differing in the tilt angle
of dsDNA respect to XPG. This suggests that swiveling of
XPG on dsDNA may play a role in protein function. Swivel-
ing is supported by comparison with Rad2-DNA structures
in the activated stated, which suggests that pivoting of ds-
DNA on 11 would position the nucleic acid for nuclease
attack (Movie 1). Repositioning of DNA for cleavage likely
associates with binding, at the protein–DNA interface, of
monovalent cations such as K+, like in Rad2 (25), Na+,
observed in EXO1 (35), or Li+, which we report to be as
productive as K+ for XPG activity (Supplementary Figure
S2C). Besides, the major groove binding mode likely rep-
resents a non-productive complex. Nevertheless, this pecu-
liar interaction raises the possibility of DNA scanning by
sliding on the DNA, rather than by rotation around the
DNA minor groove. This is supported by structural stud-
ies in EXO1, showing that the H2TH is able to slide by 1
nucleotide, assisted by the monovalent ion mediating the in-
teraction (35).
The hydrophobic wedge and the -pin form a DNA-binding
canyon
In addition to the main DNA contact point around the
H2TH motif, the hydrophobic wedge and the -pin con-
tact a symmetry-related DNA molecule in our structures.
Notably, by inserting into the major groove of dsDNA,
the wedge loop orders in a unique configuration. The hy-
drophobic wedge and the -pin form a shallow canyon with
a positively-charged surface that reaches 15 at the outer
rim of XPGn. Modeling of a splayed-arm substrate on our
structure suggests that this canyon is the binding site for the
undamaged ssDNA strand in the repair bubble (Figure 4D).
An open canyon is compatible with experiments showing
that the 3′ overhang in splayed-arm substrates, correspond-
ing to the undamaged ssDNA strand in the repair bubble,
is not protected by XPG (34). These authors also show that
at least two nucleotides of the 3′ overhang are required to
retain XPG binding and cleavage. In agreement, our muta-
tional analysis indicates that changes in the vicinity of the
ss/dsDNA junction, including R43A/R45A and R823A,
mildly decrease DNA binding, while canyon mutants that
are more distant to the junction, such as H60A, K828E
and K972E, behave like the wild-type protein. Moreover,
residues R43 and/or R45 in the wedge loop are relevant
for proper DNA positioning before cleavage, while other
residues in the canyon have little or no influence on nu-
clease activity. An equivalent canyon in FEN1 and GEN1
is occupied by dsDNA on the 3′ side of their substrates,
which raises the possibility of dsDNA binding on the XPG
canyon at a certain stage of the repair process. In princi-
ple, XPG could simultaneously bind both dsDNA sides of
the repair bubble, in way that resembles that observed in
FEN1 or GEN1 (Figure 3). Nevertheless, the presence of
TFIIH, XPA and XPF-ERCC1 on the 5′ side of the repair
bubble likely occlude XPG access to dsDNA on this side.
Alternatively, the canyon may bind dsDNA during initial
XPG recruitment to the repair bubble, when XPF-ERCC1
is absent, which may be connected to the stimulatory role of
XPG in bubble opening by TFIIH (8).
Implications for nucleotide excision repair
Based on our results, we propose a model for XPG function
in NER (Figure 7). In the first stages, binding of TFIIH on
DNA next to the lesion precedes recruitment of XPA and
XPG (10). We hypothesize that initial recruitment of XPG
implies interaction with dsDNA in a configuration that may
mimic that observed in our crystals. In this context, the en-
zyme likely contacts DNA through its H2TH, assisted by
1 and 12b. This allows XPG to scan the dsDNA on the
3′ side of the lesion, possibly by sliding along one face of
the double helix. The canyon formed by the wedge and the
-pin may contact dsDNA on the 5′ side of the lesion, but
this remains to be confirmed. At this stage, XPG also binds
TFIIH subunits XPB and XPD using its C-terminal tail
and the N-terminal third of its spacer region, respectively,
as seen by crosslinking experiments (8). The dynamic heli-
cal arch likely mediates the transfer of information between
the spacer region and the nuclease domain. Therefore, sub-
sequent conformational changes in TFIIH can be sensed by
the helical arch, which can transfer the information to the
wedge. This likely orchestrates swiveling of XPG on the ds-
DNA using 11 as pivoting point so that the protein adopts
a pre-activated configuration on DNA. Upon DNA cleav-
age XPF-ERCC1 on the 5′ side of the lesion, further rear-
rangements of the repair complex likely lead to correct po-
sitioning of the undamaged ssDNA strand in the canyon
formed by the wedge and the -pin, and accommodation
of the scissile bond near the active site. Whether the long 5′
flap is threaded through the gateway requires further inves-
tigation. This activated configuration would lead to XPG-
mediated DNA cleavage on the 3′ side of the lesion. Finally,
the damaged oligonucleotide is eliminated prior to comple-
tion of DNA repair.
A new framework for therapeutic applications
The crystal structures reported here provide an atomic
framework to understand the molecular basis of XP and
CS. Severe phenotypes associate with significant structural
damage within the XPG hydrophobic core or around the
main DNA-interacting region, i.e. the H2TH motif or he-
lix 12b. In contrast, milder phenotypes generally associate
with minimal structural damage in those areas, reduced mo-
bility of structural motifs, or reduced protein stability, as we
show for mutants A792V, A795T and W968C. Besides, our
structures can assist the development of compounds able to
modulate the activity of this essential player in the repair of
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Figure 7. Model of the XPG role in NER. XPG is in blue with arch he-
lices in cyan and regions of unknown structure as dashed lines. Horizontal
black arrows denote recruitment or dissociation from the repair complex,
while curved red double-arrows indicate mobility and straight red double-
arrows indicate putative XPG-DNA interactions. Red single arrows denote
incision by XPF-ERCC1 and XPG nucleases.
with the effectiveness of different chemotherapeutic agents
used in cancer treatment. Intriguingly, high XPG levels cor-
relate both with sensitivity to trabectedin and with resis-
tance to cisplatin chemotherapy in ovarian, colon and XP
cell lines (50). The atomic structures of XPG constitute a
valuable tool to design inhibitors that could combined with
cisplatin or equivalent drugs in tumors refractory to these
compounds.
During final stages of revision of this work, a related
study was published (51). This integrated structural study
includes the structure of a DNA-free XPG construct, where
the XPG helical arch had been replaced by that of Pyrococ-
cus furiosus FEN1. This chimeric protein exhibits a fixed
orientation for the helical arch and neighboring regions that
is distinct from that observed in the DNA-free and DNA-
bound XPG structures reported here. Further structure-
function studies are now instrumental to deepen our knowl-
edge on the essential role of XPG in DNA repair.
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